Is Nuvation Bio Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NYSE: NUVB) stock is to Buy NUVB stock.
Out of 2 analysts, 0 (0%) are recommending NUVB as a Strong Buy, 2 (100%) are recommending NUVB as a Buy, 0 (0%) are recommending NUVB as a Hold, 0 (0%) are recommending NUVB as a Sell, and 0 (0%) are recommending NUVB as a Strong Sell.
What is NUVB's forecast return on equity (ROE) for 2023-2026?
(NYSE: NUVB) forecast ROE is N/A, which is considered weak.
What is NUVB's Price Target?
According to 2 Wall Street analysts that have issued a 1 year NUVB price target, the average NUVB price target is $4.75, with the highest NUVB stock price forecast at $5.00 and the lowest NUVB stock price forecast at $4.50.
On average, Wall Street analysts predict that Nuvation Bio's share price could reach $4.75 by Aug 21, 2024. The average Nuvation Bio stock price prediction forecasts a potential upside of 241.73% from the current NUVB share price of $1.39.
What is NUVB's forecast return on assets (ROA) for 2023-2026?
(NYSE: NUVB) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.1%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.